Barwon Completes co-investment in Kent Pharmaceuticals

Barwon Investment Partners is pleased to announce the successful completion of a co-investment in UK and Ireland based generic pharmaceuticals business Kent Pharmaceuticals. The investment has been made alongside highly-regarded UK private equity manager Duke Street. Duke Street led the buyout supported by existing Chief Executive of Kent Pharmaceuticals, Debashis Dasgupta, who has previous